Safety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorectal Cancer
Clinical trial NCT03545711 · UNKNOWN
Trial details
- NCT number
- NCT03545711
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-26
- Primary completion
- 2019-11-24
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.